Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, Hao H, Xiong J.
Acta Pharm Sin B. 2022 Feb;12(2):558-580. doi: 10.1016/j.apsb.2021.09.019. Epub 2021 Sep 25.
Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis: A case series and literature review.
van Dijk MJ, van Oirschot BA, Stam-Slob MC, Waanders E, van der Zwaag B, van Beers EJ, Jans JJM, van der Linden PW, Torregrosa Diaz JM, Gardie B, Girodon F, Schots R, Thielen N, van Wijk R.
Br J Haematol. 2023 Jan;200(2):249-255. doi: 10.1111/bjh.18485. Epub 2022 Sep 30.
Erythrocyte ENT1-AMPD3 Axis is an Essential Purinergic Hypoxia Sensor and Energy Regulator Combating CKD in a Mouse Model.
Chen C, Xie T, Zhang Y, Wang Y, Yu F, Lin L, Zhang W, Brown BC, Zhang X, Kellems RE, D'Alessandro A, Xia Y.
J Am Soc Nephrol. 2023 Oct 1;34(10):1647-1671. doi: 10.1681/ASN.0000000000000195. Epub 2023 Aug 7.
The first case of a complete deficiency of diphosphoglycerate mutase in human erythrocytes.
Rosa R, Prehu MO, Beuzard Y, Rosa J.
J Clin Invest. 1978 Nov;62(5):907-15. doi: 10.1172/JCI109218.
Bisphosphoglycerate Mutase Deficiency Protects against Cerebral Malaria and Severe Malaria-Induced Anemia.
Xu G, van Bruggen R, Gualtieri CO, Moradin N, Fois A, Vallerand D, De Sa Tavares Russo M, Bassenden A, Lu W, Tam M, Lesage S, Girouard H, Avizonis DZ, Deblois G, Prchal JT, Stevenson M, Berghuis A, Muir T, Rabinowitz J, Vidal SM, Fodil N, Gros P.
Cell Rep. 2020 Sep 22;32(12):108170. doi: 10.1016/j.celrep.2020.108170.
Study of a kindred with partial deficiency of red cell 2,3-diphosphoglycerate mutase (2,3-DPGM) and compensated hemolysis.
Travis SF, Martinez J, Garvin J Jr, Atwater J, Gillmer P.
Blood. 1978 Jun;51(6):1107-16.
Hemolytic anemias and erythrocyte enzymopathies.
Valentine WN, Tanaka KR, Paglia DE.
Ann Intern Med. 1985 Aug;103(2):245-57. doi: 10.7326/0003-4819-103-2-245.
Metabolic myopathies.
DiMauro S, Miranda AF, Sakoda S, Schon EA, Servidei S, Shanske S, Zeviani M.
Am J Med Genet. 1986 Dec;25(4):635-51. doi: 10.1002/ajmg.1320250406.
Biphosphoglycerate Mutase: A Novel Therapeutic Target for Malaria?
Azzuolo A, Yang Y, Berghuis A, Fodil N, Gros P.
Transfus Med Rev. 2023 Jul;37(3):150748. doi: 10.1016/j.tmrv.2023.150748. Epub 2023 Jul 13.
Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.
Hoyer JD, Allen SL, Beutler E, Kubik K, West C, Fairbanks VF.
Am J Hematol. 2004 Apr;75(4):205-8. doi: 10.1002/ajh.20014.
